Magnesium Hydroxide Dosing for Bowel Preparation
Magnesium hydroxide is NOT recommended as a primary bowel preparation agent for colonoscopy, and standard FDA-approved dosing for laxative use is 30-60 mL (2,400-4,800 mg) once daily, not the higher doses required for adequate bowel preparation.
Critical Context: Wrong Agent for Bowel Prep
The available evidence addresses magnesium oxide for chronic constipation and magnesium sulfate for bowel preparation—not magnesium hydroxide specifically for colonoscopy prep. This distinction matters significantly for safety and efficacy.
FDA-Approved Laxative Dosing
For standard laxative use (not bowel preparation), the FDA label specifies 1:
- Adults and children >12 years: 30-60 mL (2,400-4,800 mg) once daily
- Preferably taken at bedtime
- Must drink a full 8 oz glass of liquid with each dose
- Do not exceed maximum recommended daily dose in 24 hours
Why This Matters for Bowel Prep
The 2025 US Multi-Society Task Force guidelines on colonoscopy bowel preparation do not include magnesium hydroxide as a recommended regimen 2. The guideline discusses:
- High-volume PEG (4L)
- Low-volume PEG (2L) with ascorbate
- Ultra-low-volume preparations (sodium picosulfate with magnesium citrate, oral sulfate solution)
Notably, magnesium citrate and magnesium sulfate appear in bowel prep protocols, but magnesium hydroxide does not.
Safety Concerns with Magnesium Compounds
The 2018 ESMO guidelines explicitly warn that saline laxatives (including magnesium hydroxide) should be used with caution in older adults due to hypermagnesemia risk 3. The 2023 AGA/ACG guidelines on chronic constipation recommend magnesium oxide at only 1.5 g/day for constipation management, with clear warnings to avoid use in patients with renal insufficiency 4.
Clinical Pitfalls
- Renal function: Magnesium-based laxatives accumulate in kidney disease, causing hypermagnesemia 1
- Inadequate preparation: Research shows magnesium hydroxide added to PEG reduced solid stool but did not improve overall preparation quality 5
- Drug interactions: Must check for interactions with prescription medications 1
- Volume overload risk: Hyperosmotic preparations are contraindicated in patients at risk for electrolyte disturbances 2
Recommended Approach
For bowel preparation, use FDA-approved colonoscopy prep agents 2:
- First choice: Low-volume PEG (2L) with ascorbate—better tolerability with equivalent efficacy
- Alternative: High-volume PEG (4L) if concerned about preparation adequacy
- Consider: Sodium picosulfate with magnesium citrate or oral sulfate solution
If using magnesium hydroxide only as an adjunctive laxative (not primary bowel prep):
- Maximum 60 mL (4,800 mg) daily per FDA labeling 1
- Screen for renal insufficiency first 4
- Monitor for hypermagnesemia if used >1 week 1
- Ensure adequate hydration
Absolute Contraindications
- Creatinine clearance <30 mL/min
- Pre-existing hypermagnesemia
- Magnesium-restricted diet
- Bowel obstruction or perforation risk 1